Everence Capital Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $155K | Buy |
+13,420
| New | +$155K | 0.01% | 770 |
|
|
2024
Q3 | – | Sell |
-42,210
| Closed | -$667 | – | 766 |
|
|
2024
Q2 | $667 | Hold |
42,210
| – | – | 0.05% | 306 |
|
|
2024
Q1 | $721 | Hold |
42,210
| – | – | 0.05% | 296 |
|
|
2023
Q4 | $745K | Hold |
42,210
| – | – | 0.05% | 283 |
|
|
2023
Q3 | $1.01K | Sell |
42,210
-9,650
| -19% | -$232 | 0.08% | 210 |
|
|
2023
Q2 | $1.13M | Hold |
51,860
| – | – | 0.09% | 187 |
|
|
2023
Q1 | $1.14K | Hold |
51,860
| – | – | 0.09% | 188 |
|
|
2022
Q4 | $1.05K | Sell |
51,860
-10,580
| -17% | -$214 | 0.09% | 191 |
|
|
2022
Q3 | $842K | Buy |
62,440
+14,450
| +30% | +$195K | 0.08% | 223 |
|
|
2022
Q2 | $951K | Buy |
47,990
+7,610
| +19% | +$151K | 0.08% | 193 |
|
|
2022
Q1 | $1.28M | Sell |
40,380
-10,600
| -21% | -$335K | 0.1% | 172 |
|
|
2021
Q4 | $1.14M | Buy |
50,980
+11,310
| +29% | +$252K | 0.08% | 201 |
|
|
2021
Q3 | $1.1M | Buy |
39,670
+180
| +0.5% | +$5K | 0.09% | 185 |
|
|
2021
Q2 | $1.54M | Hold |
39,490
| – | – | 0.13% | 134 |
|
|
2021
Q1 | $1.14M | Sell |
39,490
-12,040
| -23% | -$347K | 0.1% | 166 |
|
|
2020
Q4 | $1.37M | Buy |
51,530
+12,170
| +31% | +$323K | 0.13% | 131 |
|
|
2020
Q3 | $601K | Buy |
39,360
+26,640
| +209% | +$407K | 0.07% | 238 |
|
|
2020
Q2 | $257K | Buy |
+12,720
| New | +$257K | 0.03% | 499 |
|